In-111 pentetreotide. Superior imaging agent for gastrinomas

Area of Science:

• Endocrinology
• Nuclear Medicine
• Surgical Oncology

Background:

• Gastrinomas, neuroendocrine tumors secreting gastrin, cause Zollinger-Ellison syndrome.
• Accurate tumor localization is crucial for surgical resection and patient management.
• Standard imaging techniques include ultrasound, CT, MRI, angiography, and venous sampling.

Observation:

• A patient presented with a suspected gastrinoma.
• Conventional imaging modalities (CT, MRI, angiography) failed to localize the tumor.
• Indium-111 pentetreotide scintigraphy was employed for localization.

Findings:

• Indium-111 pentetreotide scintigraphy successfully identified the gastrinoma.
• The lesion's location was confirmed during subsequent surgical exploration.
• This highlights the utility of somatostatin receptor imaging in challenging cases.

Implications:

• Indium-111 pentetreotide imaging offers a valuable tool for localizing gastrinomas when other methods fail.
• Improved localization can lead to more effective surgical interventions.
• This case underscores the importance of considering advanced nuclear imaging in complex neuroendocrine tumor diagnosis.